(KE) Kimball Electronics - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US49428J1097

Electronics, Assemblies, Contract-Manufacturing, Medical-Disposables

Electronic Manufacturing Services
Market Cap in USD: 691m

IPO / Inception: 2014-11-03
12m vs SPY: 26.8%

EPS (Earnings per Share)

EPS CAGR: 26.99%
EPS Trend: -19.9%

Last SUE: 2.51
Qual. Beats: 4

Revenue

Rev. CAGR: 4.03%
Rev. Trend: -3.3%

Last SUE: 1.08
Qual. Beats: 3

Dividends

Currently no dividends paid

Risk via 5d forecast
Volatility	40.0%
Value at Risk 5%th	59.7%
Relative Tail Risk	-9.31%

Reward TTM
Sharpe Ratio	1.04
Alpha	30.03
CAGR/Max DD	0.09

Character TTM
Hurst Exponent	0.577
Beta	1.198
Beta Downside	1.400

Drawdowns 3y
Max DD	58.50%
Mean DD	24.92%
Median DD	25.38%

Description: KE Kimball Electronics December 27, 2025

Kimball Electronics (NASDAQ:KE) is a contract manufacturing organization that delivers end-to-end electronics solutions-including PCB assembly, precision-molded plastics, cold-chain logistics, and product sterilization-for automotive, medical, and industrial customers. The firm also provides design-for-manufacturing, rapid prototyping, reliability testing, and aftermarket lifecycle services across a global footprint that spans the United States, China, Mexico, Europe, and Southeast Asia.

In its most recent fiscal year (2023), Kimball reported approximately $1.5 billion in revenue with an operating margin near 5%, and a backlog of roughly $500 million, indicating a moderate but stable order pipeline. The company’s earnings per share (EPS) trended upward year-over-year, driven largely by higher utilization rates in its automotive and medical segments.

Key macro-level drivers for Kimball include the accelerating shift toward electric-vehicle (EV) platforms, which is boosting demand for high-precision electronic modules, and the continued outsourcing of medical-device production to specialist manufacturers to meet stringent regulatory and sterilization requirements. Additionally, the sector benefits from a resilient US manufacturing PMI (averaging 53-55 in 2023) and from supply-chain diversification trends that favor multi-regional production footprints.

For a deeper quantitative assessment of KE’s valuation dynamics, you may find it useful to explore the analytics available on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (23.9m TTM) > 0 and > 6% of Revenue (6% = 88.7m TTM)

FCFTA 0.11 (>2.0%) and ΔFCFTA 5.80pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 25.61% (prev 26.59%; Δ -0.98pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.14 (>3.0%) and CFO 146.5m > Net Income 23.9m (YES >=105%, WARN >=100%)

Net Debt (61.8m) to EBITDA (83.5m) ratio: 0.74 <= 3.0 (WARN <= 3.5)

Current Ratio 2.21 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (24.9m) change vs 12m ago -1.29% (target <= -2.0% for YES)

Gross Margin 7.42% (prev 7.77%; Δ -0.36pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 132.7% (prev 143.7%; Δ -10.91pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 3.26 (EBITDA TTM 83.5m / Interest Expense TTM 14.3m) >= 6 (WARN >= 3)

Altman Z'' 4.35

(A) 0.35 = (Total Current Assets 690.6m - Total Current Liabilities 312.0m) / Total Assets 1.08b

(B) 0.32 = Retained Earnings (Balance) 343.6m / Total Assets 1.08b

(D) 0.69 = Book Value of Equity 345.1m / Total Liabilities 500.8m

Total Rating: 4.35 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 56.92

1. Piotroski 5.0pt

2. FCF Yield 15.37%

3. FCF Margin 7.83%

4. Debt/Equity 0.24

5. Debt/Ebitda 0.74

6. ROIC - WACC (= -2.98)%

7. RoE 4.28%

8. Rev. Trend -3.28%

9. EPS Trend -19.85%

What is the price of KE shares?

As of January 12, 2026, the stock is trading at USD 28.35 with a total of 153,412 shares traded.
Over the past week, the price has changed by -0.60%, over one month by -9.51%, over three months by -0.04% and over the past year by +53.16%.

Is KE a buy, sell or hold?

Kimball Electronics has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy KE.

Strong Buy: 3
Buy: 0
Hold: 1
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the KE price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	33	16.4%
Analysts Target Price	33	16.4%
ValueRay Target Price	30.8	8.5%

KE Fundamental Data Overview January 12, 2026

P/E Trailing = 29.5313
P/S = 0.4678
P/B = 1.1955
Beta = 1.152
Revenue TTM = 1.48b USD
EBIT TTM = 46.6m USD
EBITDA TTM = 83.5m USD
Long Term Debt = 130.9m USD (from longTermDebt, last quarter)
Short Term Debt = 6.60m USD (from shortTermDebt, last quarter)
Debt = 137.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 61.8m USD (from netDebt column, last quarter)
Enterprise Value = 753.2m USD (691.4m + Debt 137.5m - CCE 75.7m)
Interest Coverage Ratio = 3.26 (Ebit TTM 46.6m / Interest Expense TTM 14.3m)
EV/FCF = 6.50x (Enterprise Value 753.2m / FCF TTM 115.8m)
FCF Yield = 15.37% (FCF TTM 115.8m / Enterprise Value 753.2m)
FCF Margin = 7.83% (FCF TTM 115.8m / Revenue TTM 1.48b)
Net Margin = 1.62% (Net Income TTM 23.9m / Revenue TTM 1.48b)
Gross Margin = 7.42% ((Revenue TTM 1.48b - Cost of Revenue TTM 1.37b) / Revenue TTM)
Gross Margin QoQ = 7.89% (prev 8.01%)
Tobins Q-Ratio = 0.70 (Enterprise Value 753.2m / Total Assets 1.08b)
Interest Expense / Debt = 1.71% (Interest Expense 2.35m / Debt 137.5m)
Taxrate = 8.30% (913.0k / 11.0m)
NOPAT = 42.8m (EBIT 46.6m * (1 - 8.30%))
Current Ratio = 2.21 (Total Current Assets 690.6m / Total Current Liabilities 312.0m)
Debt / Equity = 0.24 (Debt 137.5m / totalStockholderEquity, last quarter 577.1m)
Debt / EBITDA = 0.74 (Net Debt 61.8m / EBITDA 83.5m)
Debt / FCF = 0.53 (Net Debt 61.8m / FCF TTM 115.8m)
Total Stockholder Equity = 558.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.15% (Net Income 23.9m / Total Assets 1.08b)
RoE = 4.28% (Net Income TTM 23.9m / Total Stockholder Equity 558.2m)
RoCE = 6.77% (EBIT 46.6m / Capital Employed (Equity 558.2m + L.T.Debt 130.9m))
RoIC = 5.90% (NOPAT 42.8m / Invested Capital 725.0m)
WACC = 8.88% (E(691.4m)/V(828.9m) * Re(10.33%) + D(137.5m)/V(828.9m) * Rd(1.71%) * (1-Tc(0.08)))
Discount Rate = 10.33% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.60%
[DCF Debug] Terminal Value 66.34% ; FCFF base≈92.2m ; Y1≈60.5m ; Y5≈27.6m
Fair Price DCF = 16.71 (EV 468.5m - Net Debt 61.8m = Equity 406.7m / Shares 24.3m; r=8.88% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -19.85 | EPS CAGR: 26.99% | SUE: 2.51 | # QB: 4
Revenue Correlation: -3.28 | Revenue CAGR: 4.03% | SUE: 1.08 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.33 | Chg30d=-0.030 | Revisions Net=+0 | Analysts=4
EPS current Year (2026-06-30): EPS=1.35 | Chg30d=+0.085 | Revisions Net=+2 | Growth EPS=+20.3% | Growth Revenue=-5.6%
EPS next Year (2027-06-30): EPS=1.50 | Chg30d=+0.062 | Revisions Net=+2 | Growth EPS=+11.7% | Growth Revenue=+4.7%

Additional Sources for KE Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle